Claudio Marino

Federico II University Hospital

Papers

1

Total Citations

13

H-Index

1

About

Claudio Marino is a urologic surgeon and researcher whose work centers on improving prostate cancer diagnosis and treatment, particularly through the integration of multiparametric magnetic resonance imaging (mpMRI) and robot-assisted surgery. His major contributions include identifying key predictive factors for adverse histopathological features at robot-assisted radical prostatectomy (RARP), such as cribriform variant status and perineural invasion. His landmark 2023 study, with 13 citations, demonstrated how mpMRI findings can predict upgrading between biopsy and final histology, directly informing surgical planning and patient counseling. Marino’s research has practical impact, helping clinicians stratify risk and refine treatment decisions in the era of precision oncology. His work at a single tertiary referral center provides valuable real-world data that bridges imaging, pathology, and surgical outcomes. By clarifying the predictors of aggressive disease features, Marino contributes to more personalized management of prostate cancer, reducing overtreatment while ensuring high-risk patients receive timely intervention.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center
13 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Federico II University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago